US Stock MarketDetailed Quotes
NPCE NeuroPace
- 10.250
- +0.050+0.49%
Close Nov 27 16:00 ET
- 10.250
- 0.0000.00%
Post 20:01 ET
305.94MMarket Cap-10459P/E (TTM)
10.460High9.790Low61.62KVolume10.200Open10.200Pre Close620.71KTurnover0.47%Turnover RatioLossP/E (Static)29.85MShares18.15052wk High31.16P/B134.16MFloat Cap5.45052wk Low--Dividend TTM13.09MShs Float27.380Historical High--Div YieldTTM6.57%Amplitude1.220Historical Low10.072Avg Price1Lot Size
About NeuroPace Company
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Company Profile
SymbolNPCE
Company NameNeuroPace
Listing DateApr 22, 2021
Issue Price17.00
Founded1997
CEOMr. Joel Becker
MarketNASDAQ
Employees171
Fiscal Year Ends12-31
Address455 North Bernardo Avenue
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94043
Phone1-650-237-2700
Websitehttp://www.neuropace.com
Company Executives
- Name
- Position
- Salary
- Joel Becker
- Director, President and Chief Executive Officer
- 1.51M
- Dr. Martha Morrell, M.D.
- Chief Medical Officer
- 1.11M
- Rebecca Kuhn
- Principal Accounting Officer, Chief Financial Officer, Corporate Secretary and Vice President, Finance and Administration
- 994.91K
- Frank M. Fischer
- Chairman of the Board
- 152.85K
- Dr. Uri Geiger
- Independent Director
- 218.80K
- Joseph S. Lacob
- Independent Director
- 111.53K
- Renee Ryan
- Independent Director
- 124.03K
- Rakhi Kumar
- Independent Director
- 126.53K
- Lisa Andrade
- Independent Director
- 125.45K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data